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Abstract— Surgical site infections and complications (SSI,
SSC) are relatively rare but potentially devastating events;
particularly in cardiac surgery because of the importance of
the structures involved.
In accordance with the main international guidelines, that
recommend the use of negative pressure therapy in closed
surgical wounds (ciNPWT) in high-risk patients, we selected
a group of 112 patients at high risk of developing surgical site
complications, presenting in the clinic from January 2018 to
December 2019.
We applied 165 single-use negative pressure dressings in our
cohort and kept them for seven days (± 1). All the wounds were
closed by primary intention without edema or hematoma. Three
cases of postoperative bleeding required us to pause the negative
pressure therapy. After discharge, five patients at particularly
high risk developed sternal wound dehiscence.
In conclusion, the use of ciNPWT, applied following a
dedicated algorithm, gave good results in the prevention of SSI
or SSC. Some limitations in the results are determined by the
specific requirements of cardiac surgery.
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Introduction
THE onset of complications and infections of the surgicalsite (SSC, SSI) are of great impact both in terms of
therapy costs and fatality rate. It requires to revisit the use
of resources, and evalutae patient’s quality of life.
Surgical site infections occurs in up to 5% of patients fol-
lowing surgical procedures. Its occurence increases average
hospital length-of-stay by approximately 9.7 days, risk of
mortality by 2 to 11-fold, and costs of hospitalization by
more than $20000 per admission.1
Deep sternal wound infection (DSWI) remains a major
concern in cardiac surgery. The impact of this complication
is particularly related to the increasing proportion of patients
at high risk of infection as well as to the many patient-
related and surgery-related risk factors involved in their
pathogenesis2
In 2016, the World Health Organization issued guidelines
for the prevention of surgical site infections3 in which, it sug-
gested, as a conditional recommendation, the use of prophy-
lactic negative pressure on surgical wounds with a high risk
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of dehiscence or infection. A consensus document from the
World Union of Wound Healing Societies (WUWHS) listed
which were the main general and specific risk factors of the
main surgeries for the appearance of wound complications.4
Meta-analysis and Randomized Controlled Trials showed the
efficacy of PICO system (Smith&Nephiew, Hull, UK) in
preventing surgical site complications in general, obstetric
and cardiac surgery.5, 6 Afterwards, the NICE guidelines
published in 2019 recommended the PICO device in case
of surgical wounds at risk of dehiscence.7
There is an increasing body of evidence to suggest that
negative pressure wound therapy (NPWT) could be effective
in reducing the risk of postoperative wound complications
including SSI.8, 9
In concordance with the position papers we tried to iden-
tify the most important risk factors and rate of SSI/SSC in
cardiac surgery in our department.
Materials and methods
Inclusion criteria
Since January 2018, we have applied a single-use negative
pressure dressing following sternal or safenectomy surgery
to surgical wounds in patients who met the predefined risk
criteria: obesity or cachexia, diabetes, kidney disease, age >
65, COPD, use of steroid or antiplatelet drugs, recent previ-
ous hospitalization, ongoing infection, heart failure, hypoal-
buminemia, anemia) or the type of intervention the patient
underwent (prolonged intervention, emergency procedure,
need for deep hypothermia / circulatory arrest, harvesting of
both mammary arteries, prolonged extracorporeal circulation,
tensioned surgical suture, surgical revision of the wound).
A flowchart was created in which these parameters were
divided into major and secondary after consultation with
colleagues of various specialties, to facilitate the decision-
making process. Major risk factors (only one sufficient) are
a BMI greater than 35 or less than 18 kg/m2, glycated
hemoglobin greater than 9%, renal failure requiring dialysis,
operation lasting longer than 360 minutes or performed
in hypothermia or with circulatory arrest or in emergency
conditions.
Secondary risk factors (at least 2 necessary) were: BMI
between 30 and 35 kg/m2, glycated hemoglobin between 7
and 9%, COPD in therapy, renal clearance lower than 30
mL / min, ongoing therapy with steroids or with combined
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Males (%) 76 (67.8%)
Average age (years) 70 (range 44-86)
Sternal dressings (n) 111
Left leg dressings (n) 39
Right leg dressing (n) 15
CABG (n) 48 (42.9%)
CABG + valves (n) 28 (25%)
Replace aortic valve (n) 10 (8.9%)
Aortic vascular surgery (n) 8 (7.1%)
Sternal resynthesis (n) 7 (6.3%)
Mitral surgery (n) 5 (4.5%)
Other (n) 6 (5.4%)
antiplatelet agents (DAPT), peripheral artery disease, re-
peated or recent hospitalization, an ongoing antibiotic therapy
for a major infection, left ventricular ejection fraction less
than 30%, hypoalbuminaemia (less than 2.5 g albumin/dL),
anemia (Hb minor of 10 g/dL for women, 11 g/dL for
males), both mammary arteries harvested, extracorporeal
circulation> 180 minutes, a suture performed under tension,
a surgical revision.
Procedure
The device consisted of an absorbent, breathable, mul-
tilayer, adhesive dressing connected to a battery-operated
disposable pump that guarantees the delivery of negative
pressure of -75 mmHg for the duration of about 7 days.
The silicone adhesive layer is atraumatic and comfortable
for patients, the absorbent layer blocks the exudate away
from the wound, the airlock technology allows a uniform
distribution of negative pressure over the whole dressing,
the external silicone layer protects the wound from external
contaminants while allowing adequate perspiration.
Following this algorithm, 112 patients were selected and
165 negative pressure dressings applied from January 2018
to December 2019. The surgery that the majority of patients
underwent was coronary artery bypass grafting (Tab. I).
As specified above, once one of the major risk factors or at
least two of the secondary risk factors were met, the dressing
was applied directly in the operating room at the end of the
intervention after cleaning the site of the incision with saline
solution.
A change of dressing was foreseen in the 2nd-3rd postop-
erative day if there was a detachment due to the removal of
drainage or in case of excessive saturation of the pad (Fig.
1).
Usually, the dressing was removed at the end of the 7-day-
period (unless the patient was discharged earlier: in this case
the dressing was discontinued on the day of discharge as the
management of the device was not planned at rehabilitation
centers) (Fig. 2).
Discussion
The identified risk factors were detected 352 times, 3.14
per patient; the most frequent (>= 12.5%) were: removal
Figure 1. Third postoperative day: medication change (no signs of seroma
or hematoma, blood-clots, the wound edges are close together) Third
postoperative day: dressing change (the dressing adsorbed a good amount
of exudate)
Figure 2. Seventh postoperative day: dressing removal (the wound is closed
in first intention). Seventh postoperative day: dressing removal (the dressing
is quite clean)
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Table II
Risk factors and their frequency of dectection; major risk factors are
indicated in bold letter




Procedure>360 min 6 5.36%
Emergency 13 11.61%









recent hospitalization 24 21.43%




BIMA harvested 52 46.43%
ECC>180’ 7 6.25%
Suture under tension 24 21.43%
Surgical revision 9 8.06%
352
of the double mammary artery 46.4%, senior age 33.9%,
decompensated diabetes 27.7%, moderate obesity 22.3%, the
tension on the suture and reoperation 21.4%, severe obesity,
and diabetes severely decompensated 13.4%, moderate-to-
severe renal failure 12.5% (Tab. II).
Of the 165 dressings applied 142 (86%) showed no com-
plications, in 7 cases (4.2%) there was an early interruption
of use (1 technical error at the beginning of this experience,
1 device malfunction, 1 pump loss (sic!), 4 early deaths.
The remaining 16 dressings (9.7%) presented minor prob-
lems, except in 3 cases (1.8%) in which, due to excessive
bleeding, we decided to discontinue therapy (in a fourth case
the soaked dressing has been replaced as per protocol and the
problem has not re-occurred) (Tab. III).
Results
In four cases it was not possible to evaluate the results
as the patients died early (before the 24 hours post-op),
in a fifth case the patient died from a multi-organ failure
after removing the dressing with a good result limited to the
conditions of the surgical wound.
The remaining cases had an immediate positive result with
well-matched wound edges and the absence of perilesional
edema or hematoma.
In five cases, however, the patients, after discharge, suf-
fered from sternal dehiscence (1 patient with dialitic kidney
insufficiency, 3 patients with decompensated diabetes, 1
patient with a significant tickling cough during the postop-
erative period). Only 3 of these patients required systemic
antibiotic therapy for wound infection. All healed after
surgical revision of the wound.
In 7 cases the dressing was used after a resynthesis of
the wound dehiscence. In 3 of these cases the device wasn’t
applied even if the patient matched the criteria.
Conclusions
The mechanisms of action of traditional negative pressure
medication have been well known for years. The prophylactic
application in surgical wounds in patients at risk is a rather
recent use of NPWT. The rationale for its use is based on
the general principles and in particular on the prevention of
the accumulation of liquids in layers underlying the incision
and in the prevention of tensioning of the wound edges.
In our experience, the use of preventive negative pressure
has given more than satisfactory results allowing, even in
patients at high risk, for excellent wound healing. No seromas
or hematomas nor skin changes were present throughout this
study.
The adverse events related to the use of the dressing
were episodic and of minimal intensity, however, no special
measures have been taken except in three cases where the
discontinuation of NPWT was necessary.
No superficial or deep wound dehiscence occurred during
the same hospitalization of the intervention.
However, some peculiarities of our type of surgery proba-
bly partially reduce the effect of the ciNPWT: the dressings
of predetermined dimensions do not always well adapt to
the incision, since there is little space beyond the edges of
the wound, between the jugule and the emergency of the
drainages and this, in some circumstances, prevented its use,
even if indicated.
In addition, our main surgical access is characterized by
the presence below the soft tissues (muscle band, dermis,
epidermis) of a bone structure, the sternum, which although
re-synthesized at the end of the intervention, is often severely
devascularized and subjected to continuous and sometimes
improper stress of great intensity; this peculiarity means that
the surface pressure exerted by the negative pressure dressing
is not always able to contrast the traction forces exerted on
the sternal stumps so that when a small diastasis occurs, the
process can no longer be antagonized.
The use of a flowchart through which it is possible to
identify the patients most at risk of wound dehiscence was a
certainly useful tool for mitigating costs.
Limitations
The are several limitations of this observational study: the
most important is the lack of a control group that can define
the real effectiveness of ciNPWT.
In addition, the list of risk factors used to define the
population on which to apply the negative pressure dressing,
although it was created following the international literature
available, would require a statistical analysis to define which
of these factors are the most important in the increase the risk
of adverse events. Lastly long-term follow-up is missing.
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Table III
Complications arose during use Sternum not valuable: 1 early removal, 1 malfunction, 4 deaths <12h Left leg not valuable: 1 pump loss
Sede Number w/o compli-
cation
Not valuable Bleeding Hematoma Serosity Detachment Dehiscence Blister
Sternum 111 94 6 2 1 3 3 2 0
Left leg 39 35 1 0 0 1 0 1 1
Right leg 15 13 0 2 0 0 0 0 0
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